A younger version of my dad lived for spontaneity. In his late teens and early 20s, he hitchhiked around the country in the spirit of adventure. One of his most significant early journeys took him from his home state of Michigan to Alaska, where he found work in a local…

Blood levels of certain protein markers previously linked to Alzheimer’s disease may help predict dementia risk in people with Parkinson’s disease, according to a new study. Although the findings need to be confirmed in larger studies, the results suggest that these two markers, pTau217 and pTau231, may eventually help…

The fishing aisle at Bass Pro Shops was the last place I expected to leave with a memory I’ll never forget. My Uncle Brandon and I were getting ready for one of his favorite escapes: a fishing trip. Long before Parkinson’s disease entered our lives, fishing was one of…

Once-daily treatment with tavapadon, an experimental oral small molecule being developed by Abbvie, outperformed a placebo at easing motor symptoms and problems with daily functioning in people with early Parkinson’s disease, while somnolence, or excessive sleepiness, and impulse control disorders occurred infrequently. These are six-month data from…

Specialists evaluating cognitive impairment in people with Parkinson’s disease rely on much more than the score from a commonly used cognitive screening test. They also look for patterns in how patients performed on the test alongside their medical history and other health-related information, according to a new U.S. study.